Medical Research News and Research

RSS

Organochloride pesticide exposure can alter semen quality in young people

Two in 10 young people in South East Spain have poor sperm density, which involves requiring more time to accomplish fertilization. The most common means of exposure to pesticides is food and other household products.

23 Mar 2011

Cardiff study discovers protein that protects pancreatic cells against alcohol effects

A Cardiff University-led study has discovered that a protein provides protection against the effects of alcohol in the pancreas.

23 Mar 2011

NIH spending at risk in budget battle

When House Republicans took power in 1995 determined to cut spending in a battle that shut down the U.S. government, then-House Speaker Newt Gingrich was persuaded to spare the National Institutes of Health.

21 Mar 2011

Ethnicity, depression, lack of exercise are major risk factors for chronic fatigue syndrome

Chronic fatigue syndrome (CFS) is characterized by unexplained and debilitating tiredness and is associated with headaches, disrupted sleep, muscle pain and difficulty in concentrating. New research published by BioMed Central's open access journal BMC Medicine shows that ethnicity, depression, lack of exercise or social support, and social difficulties are major risk factors for CFS.

21 Mar 2011

Scant high-quality research on hospice care in nursing homes

A new evidence review finds that there's scant high-quality research on the best comprehensive strategies for nursing homes hoping to ease the suffering of older patients through hospice care.

18 Mar 2011

MMRF earns AAHRPP accreditation for human subject protection during clinical research

The Minneapolis Medical Research Foundation at Hennepin County Medical Center (HCMC) is pleased to announce that it has earned full accreditation from the Association for the Accreditation of Human Research Protection Programs.

18 Mar 2011

Transcranial LED-based light therapy improves cognitive function in traumatic brain injury patients

At-home, daily application of light therapy via light-emitting diodes (LEDs) placed on the forehead and scalp led to improvements in cognitive function and post-traumatic stress disorder in patients with a traumatic brain injury (TBI), according to a groundbreaking study published in Photomedicine and Laser Surgery, a peer-reviewed journal published by Mary Ann Liebert, Inc.

18 Mar 2011

Gene therapy for Parkinson’s: It works!

A latest study has shown that gene therapy may be successful in treating the dreaded brain degenerative disease – Parkinson’s disease. Neurologists are hopeful that it could be useful in other neurologic disorders too.

17 Mar 2011

Harvard, UCI receive $2 million CDC grant to help reduce hospital-borne MRSA infections

A UC Irvine infectious disease specialist will be part of a nationwide Centers for Disease Control and Prevention research program to develop and test innovative approaches to reducing infection in healthcare settings.

17 Mar 2011

New study: Positive outcomes from gene therapy trial in patients with Parkinson's

A multi-center gene therapy trial for patients with advanced Parkinson's disease demonstrated reduced symptoms of the progressive movement disorder, according to a new study published in Lancet Neurology.

17 Mar 2011

Digna Biotech and Biotecnol to begin CT-I Phase I trial in healthy volunteers

Digna Biotech and Biotecnol announced today that the Spanish Regulatory Medicine Agency has authorized the start of a Phase I Clinical Trial in healthy volunteers for Cardiotrophin-I.

17 Mar 2011

The Lancet Neurology publishes Neurologix NLX-P101 Phase 2 trial results against PD

Neurologix, Inc., announced today that the results of the Company's Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease were published in an online-first edition of The Lancet Neurology.

17 Mar 2011

Ventana, CST enter license agreement for personalized cancer diagnostics

Cell Signaling Technology, Inc. of Danvers, MA, announced today that it has granted Ventana Medical Systems, Inc., a worldwide non-exclusive license to CST patent rights and proprietary antibody reagents relating to the detection of epidermal growth factor receptor mutations for the field of tissue-based in vitro diagnostic testing.

From Cell Signaling Technology 16 Mar 2011

Advances in imaging ability to discover heart defects in newborns

The Medical Imaging Laboratory in Trondheim is making advances in imaging methods for both ultrasound and magnetic resonance (MR) imaging. One benefit will be an enhanced ability to discover heart defects in newborns.

16 Mar 2011

New review finds no link between pacifiers and breastfeeding problems

Although mothers often use pacifiers to comfort cranky babies, many experts fear that they can interfere with successful breastfeeding. However, a new review finds no association between the devices and early cessation of nursing.

16 Mar 2011

Study: Statin use may reduce risk of high-grade prostate cancer

Men who take a certain class of cholesterol-lowering medicine, otherwise known as statins, may be 60 percent less likely to be diagnosed with high-grade prostate cancer.

15 Mar 2011

How male puberty begins

Scientists from Monash University have uncovered a new understanding of how male puberty begins.

14 Mar 2011

Longer looks: Best health policy picks from thought-provoking publications

Every Thursday, KHN's Jessica Marcy compiles this selection of interesting perspectives, from a variety of publications, on health care in America.

11 Mar 2011

Scientific advances at Scripps Research lay foundation for new lupus drug Benlysta

Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug Benlysta® (belimumab), approved today by the U.S. Food and Drug Administration. Benlysta®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues.

11 Mar 2011

Canadian House of Commons passes bill that could ease access to generic drugs in developing countries

Canadian lawmakers in the country's House of Commons on Wednesday "approved a bill aiming to ease the process that lets generic drug manufacturers produce patented medicines for export to poor nations at cheaper prices in a move the pharmaceutical industry says could undermine intellectual property rights," Bloomberg reports.

11 Mar 2011

Medical Research News and Research

Organochloride pesticide exposure can alter semen quality in young people

Cardiff study discovers protein that protects pancreatic cells against alcohol effects

NIH spending at risk in budget battle

Ethnicity, depression, lack of exercise are major risk factors for chronic fatigue syndrome

Scant high-quality research on hospice care in nursing homes

MMRF earns AAHRPP accreditation for human subject protection during clinical research

Transcranial LED-based light therapy improves cognitive function in traumatic brain injury patients

Gene therapy for Parkinson’s: It works!

Harvard, UCI receive $2 million CDC grant to help reduce hospital-borne MRSA infections

New study: Positive outcomes from gene therapy trial in patients with Parkinson's

Digna Biotech and Biotecnol to begin CT-I Phase I trial in healthy volunteers

The Lancet Neurology publishes Neurologix NLX-P101 Phase 2 trial results against PD

Ventana, CST enter license agreement for personalized cancer diagnostics

Advances in imaging ability to discover heart defects in newborns

New review finds no link between pacifiers and breastfeeding problems

Study: Statin use may reduce risk of high-grade prostate cancer

How male puberty begins

Longer looks: Best health policy picks from thought-provoking publications

Scientific advances at Scripps Research lay foundation for new lupus drug Benlysta

Canadian House of Commons passes bill that could ease access to generic drugs in developing countries

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Latest News